Cargando…
Li–Fraumeni-associated pancreatic neuroendocrine tumour and XAF1 p.Glu134Ter risk modifier variant
Studies have demonstrated that up to 17% of patients with pancreatic neuroendocrine tumours (pNETs) present pathogenic germline variants (PGVs) in several different genes, irrespective of family cancer history. Li–Fraumeni syndrome (LFS) is an autosomal dominant cancer predisposition syndrome relate...
Autores principales: | Riechelmann, Rachel P, Soares, Diogo C, Dias, Carla, Carraro, Dirce M, Torrezan, Giovana T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934963/ https://www.ncbi.nlm.nih.gov/pubmed/36819813 http://dx.doi.org/10.3332/ecancer.2022.1487 |
Ejemplares similares
-
Case report: p.Glu134del SOD1 mutation in two apparently unrelated ALS patients with mirrored phenotype
por: Gianferrari, Giulia, et al.
Publicado: (2023) -
Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017) -
The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report
por: Aversa, John G., et al.
Publicado: (2020) -
Li-Fraumeni-like syndrome associated with a large BRCA1 intragenic deletion
por: Silva, Amanda Gonçalves, et al.
Publicado: (2012) -
A nonsense mutation in S-antigen (p.Glu306*) causes Oguchi disease
por: Waheed, Nadia K., et al.
Publicado: (2012)